Marsh S G, Bodmer J G
Imperial Cancer Research Fund, London, United Kingdom.
Immunogenetics. 1991;33(5-6):321-34. doi: 10.1007/BF00216691.
The HLA class II sequences included in this compilation are taken from publications listed in the accompanying paper. Nomenclature for factors of the HLA system, 1990 (Bodmer et al. 1991) and Nomenclature for factors of the HLA system, 1989 (Bodmer et al. 1990). Where discrepancies have arisen between reported sequences the original authors have been contacted where possible, and necessary amendments to published sequences have been incorporated into this alignment. Future sequencing may identify errors in this list and we would welcome any evidence that helps to maintain the accuracy of this compilation. In the sequence alignments identity between residues is indicated by a hyphen (-). Unavailable sequence is indicated by an asterisk (*). Gaps in the sequence are inserted to maintain the alignment between different alleles showing variation in amino acid number.
本汇编中包含的HLA II类序列取自随附论文中列出的出版物。《HLA系统因子命名法，1990年》（博德默等人，1991年）和《HLA系统因子命名法，1989年》（博德默等人，1990年）。如果报告的序列之间出现差异，已尽可能联系原始作者，并将已发表序列的必要修正纳入此比对中。未来的测序可能会发现此列表中的错误，我们欢迎任何有助于保持本汇编准确性的证据。在序列比对中，残基之间的同一性用连字符（-）表示。不可用的序列用星号（*）表示。在序列中插入空位以保持不同等位基因之间的比对，这些等位基因在氨基酸数量上存在差异。
